Medical Device | May 20, 2026
Shaily gets regulatory nod for launch of ShailyPen Neo device technology
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
Approval for generic Semaglutide Injection strengthens CDMO partnership, enabling scalable supply from OneSource’s US FDA-approved Bengaluru facility
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
REDEMPLO is the first and only Health Canada-approved siRNA therapy for FCS
Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis
Yesintek and Yesintek I.V. are approved for the treatment of moderate to severe plaque psoriasis in adults and pediatric patients
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
This is the group’s first NoC approval in Canada
Subscribe To Our Newsletter & Stay Updated
